OMRON Healthcare Co., Ltd. announced new initiatives to accelerate its global electrocardiogram (ECG) business strategy, ...

Veterinary ECGs face added challenges, as muscle tremors, shivering and motion artifacts can easily dominate the signal.

Austin, Texas, United States, December 10th, 2025, FinanceWire HeartBeam (NASDAQ: BEAT), a medical technology company focused ...

HeartBeam (Nasdaq:BEAT) announced today that it received FDA 510(k) clearance for its 12-lead electrocardiogram (ECG) ...

HeartBeam's 1st synthesized 12-lead ECG cleared by FDA, enabling cable-free at-home arrhythmia assessment with launch set for 2026.

BOSTON, MA — A new study has shed light on which low-risk patients who have inconclusive exercise ECG tests might safely avoid additional downstream imaging tests to detect potential CAD [1]. Patients ...

We've read the fine print -- and consulted experts -- about Apple's irregular heart rhythm technology so you don’t have to. Danielle Kosecki is an award-winning journalist who has covered health and ...

A new Concordia study published in npj Biomedical Innovations suggests that a simple 30-second electrocardiogram (ECG) ...

HeartBeam Receives FDA Clearance for First-Ever, Cable-Free Synthesized 12-Lead ECG for At-Home Arrhythmia Assessment ...

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, ...